Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-49gqnnzCompleted
Randomised, open-label trial of silver diamine fluoride and GC Fuji IX GP in carious lesion (2 arms), sponsored by São Leopoldo Mandic. Primary endpoint: Arrest of enamel caries lesions. Started Feb 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-49gqnnz.